Tramadol works on your body through two distinct pathways: it activates opioid receptors in the brain to reduce pain, and it changes levels of two chemical messengers (serotonin and norepinephrine) that influence mood and pain perception. This dual action makes tramadol unusual among painkillers and explains both its effectiveness and its unique set of risks.
How Tramadol Blocks Pain
Tramadol itself is actually a relatively weak opioid. On its own, it binds to the brain’s main pain-relief receptors (mu-opioid receptors) with roughly 200 times less strength than its breakdown product. The real painkilling work happens after your liver processes tramadol into a metabolite called M1, which is up to six times more potent than tramadol at relieving pain. A liver enzyme called CYP2D6 handles this conversion, and how active that enzyme is in your body directly determines how much pain relief you get.
This matters practically because people’s CYP2D6 activity varies widely based on genetics. Some people metabolize tramadol very quickly, flooding their system with the potent M1 metabolite and increasing the risk of side effects. Others metabolize it slowly and may barely feel any pain relief at all. This genetic variability is one reason tramadol works dramatically better for some people than others, even at identical doses.
Effects on Brain Chemistry
Beyond its opioid activity, tramadol blocks the reabsorption of serotonin and norepinephrine in the brain. These two chemicals play key roles in mood regulation, stress response, and how your nervous system processes pain signals. By keeping more of them active in the gaps between nerve cells, tramadol adds a layer of pain relief that traditional opioids like morphine don’t provide.
Brain imaging studies in primates show tramadol occupies 40% to 72% of serotonin transporters and 7% to 73% of norepinephrine transporters, depending on dose. At higher doses, both systems reach over 70% occupancy. This is a significant effect on brain chemistry, comparable to what some antidepressants do, and it’s the reason tramadol carries risks that other painkillers don’t.
Common Physical Effects
The opioid side of tramadol produces familiar effects: pain relief, a sense of relaxation or mild euphoria, drowsiness, constipation, and nausea. Most people notice nausea and dizziness especially in the first few days, which often improve as the body adjusts. Constipation tends to persist for as long as you take it.
The serotonin and norepinephrine effects can cause additional symptoms like sweating, dry mouth, and headaches. Some people feel a mild mood lift or increased energy at lower doses, which is part of what gives tramadol its abuse potential despite being weaker than other opioids. At higher doses, drowsiness and mental fogginess tend to dominate.
Breathing and Respiratory Effects
One of the biggest concerns with any opioid is respiratory depression, where breathing slows dangerously. Tramadol carries this risk, and the FDA’s strongest warning (a boxed warning) specifically flags life-threatening breathing problems as a possibility. However, tramadol is notably safer than stronger opioids in this regard.
In a controlled study comparing tramadol to morphine after surgery, 13.3% of patients receiving morphine experienced oxygen levels dropping below 86%, a clinically dangerous threshold. None of the patients receiving tramadol experienced this drop. Half of the morphine patients who had breathing problems developed them after just one dose. This doesn’t mean tramadol can’t suppress breathing, especially at high doses or when combined with alcohol, sedatives, or benzodiazepines. But at standard doses used alone, the risk is substantially lower than with traditional opioids.
Seizure Risk
Tramadol lowers the seizure threshold, meaning it makes the brain more susceptible to seizures. This is a risk that most other opioids don’t carry, and it stems from tramadol’s effects on serotonin and norepinephrine rather than its opioid activity.
A large nested case-control study found that even at daily doses below 200 mg (the typical prescribed range), tramadol users had about 1.5 times the seizure risk compared to people taking low-dose codeine. At daily doses of 400 mg or more, the risk nearly doubled. The relationship between dose and seizure risk was clearest at the highest doses, but some increased risk existed across all dose levels. People with a history of seizures or epilepsy face the greatest concern, but seizures have occurred in people with no prior history.
Serotonin Syndrome
Because tramadol significantly increases serotonin activity, combining it with other drugs that raise serotonin can trigger serotonin syndrome, a potentially dangerous condition where the brain becomes overstimulated. Symptoms include agitation, rapid heartbeat, high blood pressure, fever, muscle twitching, and in severe cases, confusion or loss of consciousness.
The most common trigger is combining tramadol with antidepressants, particularly SSRIs (like fluoxetine or sertraline) or tricyclic antidepressants. The risk rises when doses of either medication increase. In rare cases, tramadol alone has caused serotonin syndrome, with at least one documented case occurring after just two pills. There’s no blood test for the condition. Diagnosis relies entirely on recognizing the pattern of symptoms, which makes awareness especially important if you take tramadol alongside any medication that affects serotonin.
Dependence and Withdrawal
Tramadol is classified as a Schedule IV controlled substance, meaning it has recognized potential for abuse and dependence, though less than Schedule II opioids like oxycodone or morphine. Its boxed warning specifically addresses the risks of addiction, abuse, and misuse.
Physical dependence can develop with regular use, even at prescribed doses. Withdrawal from tramadol is more complex than withdrawal from other opioids because it involves two systems. You can experience typical opioid withdrawal symptoms like muscle aches, sweating, anxiety, and insomnia, alongside “atypical” withdrawal symptoms caused by the sudden drop in serotonin and norepinephrine activity. These atypical symptoms can include severe anxiety, panic attacks, confusion, tingling sensations, and in some cases, hallucinations. This dual withdrawal pattern can make stopping tramadol feel different and sometimes more distressing than stopping other opioids, even though tramadol is considered weaker overall.
Why Individual Responses Vary So Much
Few painkillers produce as wide a range of individual responses as tramadol. The CYP2D6 enzyme that activates tramadol in the liver exists in several genetic variants across the population. Roughly 6% to 10% of people of European descent are “poor metabolizers” who convert very little tramadol to its active form, getting minimal pain relief. On the other end, 1% to 2% are “ultrarapid metabolizers” who produce unusually high levels of the active metabolite, increasing the risk of side effects including respiratory depression. Most people fall somewhere in between, but this genetic lottery is a major reason why two people taking the same dose can have completely different experiences.
Newborns face a specific danger highlighted by tramadol’s boxed warning: neonatal opioid withdrawal syndrome. If tramadol is used during pregnancy, the baby can be born physically dependent and experience withdrawal symptoms that require medical treatment.